Daiwa Securities Group Inc. cut its position in shares of Monsanto Co. (NYSE:MON) by 6.5% during the third quarter, Holdings Channel reports. The firm owned 36,736 shares of the company’s stock after selling 2,550 shares during the period. Daiwa Securities Group Inc.’s holdings in Monsanto were worth $3,754,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Babson Capital Management LLC bought a new position in Monsanto during the first quarter worth $1,906,000. Squarepoint Ops LLC raised its position in Monsanto by 138.6% in the first quarter. Squarepoint Ops LLC now owns 15,827 shares of the company’s stock valued at $1,389,000 after buying an additional 9,193 shares during the last quarter. Euclid Advisors LLC acquired a new position in Monsanto during the first quarter valued at approximately $1,569,000. Park National Corp OH acquired a new position in Monsanto during the second quarter valued at approximately $320,000. Finally, Baxter Bros Inc. acquired a new position in Monsanto during the second quarter valued at approximately $2,876,000. Hedge funds and other institutional investors own 73.94% of the company’s stock.
Monsanto Co. (NYSE:MON) traded down 0.65% during trading on Monday, reaching $101.89. 739,468 shares of the company’s stock were exchanged. The company has a market cap of $44.63 billion, a P/E ratio of 34.10 and a beta of 1.01. Monsanto Co. has a 12-month low of $83.73 and a 12-month high of $114.26. The stock’s 50-day moving average is $101.01 and its 200-day moving average is $103.96.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.09. The company earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. Monsanto’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.19) earnings per share. Analysts predict that Monsanto Co. will post $4.73 EPS for the current fiscal year.
Several research firms recently commented on MON. S&P Equity Research reiterated a “positive” rating on shares of Monsanto in a research note on Thursday, September 15th. Monness Crespi & Hardt dropped their target price on Monsanto from $130.00 to $128.00 and set a “buy” rating for the company in a research note on Monday, October 3rd. Vetr upgraded Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 target price for the company in a research note on Wednesday, August 3rd. TheStreet lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, September 12th. Finally, Deutsche Bank AG boosted their price target on Monsanto from $118.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, September 15th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and fifteen have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $114.06.
In other Monsanto news, EVP Steven Mizell sold 310 shares of Monsanto stock in a transaction on Monday, October 10th. The shares were sold at an average price of $103.09, for a total transaction of $31,957.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Kerry J. Preete sold 2,745 shares of Monsanto stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $100.96, for a total transaction of $277,135.20. Following the transaction, the executive vice president now directly owns 50,056 shares of the company’s stock, valued at $5,053,653.76. The disclosure for this sale can be found here. Company insiders own 0.88% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.